Skip to content
Clinical Trials – home
Sponsor

PathoBlock Therapeutics GmbH & Co. KG

Germany Leipziger Strasse 51, Mitte, 10117 Berlin, Germany

About the sponsor

PathoBlock Therapeutics GmbH & Co. KG is engaged in clinical research focused on infectious disease management, with particular interest in therapies aimed at controlling pathogen-related illness and supporting targeted treatment strategies.

  • Antimicrobial treatment
  • Pathogen-targeted therapy
  • Infection control

The sponsor’s research activity reflects involvement in therapeutic development areas where microbial disease and anti-infective approaches are central.

About Specializations

PathoBlock Therapeutics GmbH & Co. KG runs clinical trials in conditions such as Wound infection pseudomonas, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Safety and efficacy of elfucose, d‑galactose and polyhexanide solution 20% in patients with chronic wounds colonized by Pseudomonas aeruginosa

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:D-galactose
  • Sponsor:PathoBlock Therapeutics GmbH & Co. KG

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease? Our clinical trial advisor will do it for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.